Once-weekly semaglutide vs canagliflozin in type 2 diabetes: results of the SUSTAIN 8 trialI. Lingvay,A. Catarig,J. P. Frias,H. Kumar, N. L. Lausvig,C. W. le Roux,D. Thielke,A. Viljoen,R. J. McCrimmonDIABETOLOGIA(2019)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要